These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4108848)

  • 1. Heparin-protamine in prevention of graft rejection.
    Di Perri T; Grosse A; Auteri A
    Lancet; 1972 Jan; 1(7740):45. PubMed ID: 4108848
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin and protamine in graft rejection.
    Di Perri T; Grossi A; Auteri A
    Lancet; 1969 Apr; 1(7600):888. PubMed ID: 4180547
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes of the hematic level of complement in animals with skin homografts treated with heparin and protamine sulfate].
    Di Perri T; Grossi A; Auteri A; Rocco F
    Boll Soc Ital Biol Sper; 1969 May; 45(10):682-5. PubMed ID: 4923648
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of heparin and protamine sulfate on serum complement activity and on rejection phenomenon in experimental skin heterotransplants].
    Di Perri T; Grossi A; Auteri A; Carli A; Rocco F
    Boll Soc Ital Biol Sper; 1969 Aug; 45(16):1083-5. PubMed ID: 4911886
    [No Abstract]   [Full Text] [Related]  

  • 5. [Coagulolytic system and graft rejection. (Experimental study of heart homotransplantation in rabbits)].
    Baille Y; Jausseran JM; Blanc T; Isman H; Goudard A; Sicard MP; Henry E; Payan H; Lebreuil G; Sudan M; Garbe C
    Mars Med; 1972; 109(1):11-6. PubMed ID: 4553190
    [No Abstract]   [Full Text] [Related]  

  • 6. [Action of heparin and protamine sulfate on the level of hematic complement evaluated with the immuno-hemolysis method. Studies in vivo].
    Di Perri T; Grossi A; Auteri A; Rocco F
    Boll Soc Ital Biol Sper; 1969 May; 45(10):677-9. PubMed ID: 5399985
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection and treatment of canine cardiac rejection.
    Benzing G; Spitzer RE; Bove KE; Schreiber JT; Helmsworth JA
    Transplantation; 1972 Jul; 14(1):35-40. PubMed ID: 4556401
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of the heparin-protamine complex on serum complement. Research in vitro and in vivo].
    Di Perri T; Grossi A; Auteri A
    Boll Soc Ital Biol Sper; 1969 Aug; 45(16):1085-7. PubMed ID: 5374944
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement.
    Rent R; Ertel N; Eisenstein R; Gewurz H
    J Immunol; 1975 Jan; 114(1 Pt 1):120-4. PubMed ID: 234494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Action of heparin and protamine sulfate administration on serum complement levels in man].
    Di Perri T; Auteri A
    Boll Soc Ital Biol Sper; 1970 Oct; 46(20):817-9. PubMed ID: 5519564
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum lipid responses to heparin and to protamine in rabbits.
    DAY AJ; SCHWARTZ CJ; PETERS JA
    Aust J Exp Biol Med Sci; 1957 Oct; 35(5):457-65. PubMed ID: 13499169
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibodies in the serum and on the heart of dogs with cardiac allografts.
    Goldman BS; Shumak KH; Silver MD; Cartier J; Lixfeld W; Bigelow WG; Crookston JH
    Transplant Proc; 1971 Mar; 3(1):515-8. PubMed ID: 4937929
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of heparin and protamine sulfate administration on serum complement levels in a group of subjects with diseases with immunological pathogenesis].
    Di Perri T; Auteri A
    Boll Soc Ital Biol Sper; 1970 Oct; 46(20):819-21. PubMed ID: 5519565
    [No Abstract]   [Full Text] [Related]  

  • 14. ULF ballistocardiography in human cardiac transplantation.
    Shakespeare T; Reitan JA; Smith NT; Stinson EB; Shumway NE
    Bibl Cardiol; 1971; ():Suppl 27:1-9. PubMed ID: 4935282
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro.
    Bruins P; te Velthuis H; Eerenberg-Belmer AJ; Yazdanbakhsh AP; de Beaumont EM; Eijsman L; Trouwborst A; Hack CE
    Thromb Haemost; 2000 Aug; 84(2):237-43. PubMed ID: 10959695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective action of homologous serum component on graft rejection.
    Hasek M; Karakoz I; Skamene E; Chutna J; Nouza K; Bubenik J; Nemec M; Sovova V
    Transplant Proc; 1969 Mar; 1(1):527-9. PubMed ID: 4944266
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical recognition of rejection of the transplanted heart.
    Schrire V
    Laval Med; 1970 Feb; 41(2):281-4. PubMed ID: 4252259
    [No Abstract]   [Full Text] [Related]  

  • 18. Electrocardiographic changes during the unmodified rejection of heterotopic canine heart allografts.
    Semb BK; Abrahamsen AM; Barnard CN
    Scand J Thorac Cardiovasc Surg; 1971; 5(2):120-4. PubMed ID: 4939814
    [No Abstract]   [Full Text] [Related]  

  • 19. [In vitro and in vivo neutralisation of a low molecular weight heparin fraction CY 216 by protamine].
    Doutremepuich C; Bonini F; Masse A; Bousquet F; Bayrou B; Toulemonde F
    Ann Pharm Fr; 1986; 44(1):65-72. PubMed ID: 3777780
    [No Abstract]   [Full Text] [Related]  

  • 20. Electrocardiographic and vectocardiographic signs of rejection.
    Lacassagne JP; Cachera JP
    Laval Med; 1970 Feb; 41(2):276-80. PubMed ID: 4929504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.